Pilot Study of [18F]F-AraG PET Imaging to Evaluate Immunological Response to Chimeric Antigen Receptor (CAR) T Cell Therapy in Lymphoma
Latest Information Update: 19 May 2023
At a glance
- Drugs 18F-F-AraG (Primary)
- Indications B-cell lymphoma; Diffuse large B cell lymphoma; Non-Hodgkin's lymphoma
- Focus Diagnostic use
- 15 May 2023 Planned End Date changed from 1 Jun 2022 to 1 Jun 2024.
- 15 May 2023 Planned primary completion date changed from 1 Jun 2022 to 1 Jun 2024.
- 01 Nov 2021 New trial record